Dr. Graham Thomas Atkins, MD

Dr. Atkins practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Atkins' NPI, 1346576246, was assigned on October 27, 2009. Dr. Atkins holds New Hampshire license 17676.

Dr. Atkins' primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Dr. Atkins' primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Atkins is also affiliated with Cheshire Medical Center. The medical group on file is Dartmouth Hitchcock Clinics Manchester. Dmand AI also links Dr. Atkins to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Atkins practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Atkins' primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Atkins' licenses on file in 2 states: New Hampshire and Vermont.

CMS data shows 374 Medicare services from Dr. Atkins across 8 procedure codes in 2024, for 192 Medicare patients. Medicare paid $30,597 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 192 Medicare patients who saw Dr. Atkins in 2024. The largest group is 75 to 84, with 80 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Atkins' median patient age at 65, with 59% women.

In 2024, Dr. Atkins wrote 714 Medicare Part D claims for 155 patients. 36% of them were for generic drugs. CMS names the drug for 560 of them, across 12 drugs with 11 or more claims each, at $290,161 in total drug cost. In 2023, CMS named 1,617 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Atkins for performance year 2024, reported through an alternative payment model (APM). Dr. Atkins accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Atkins, published from 2019 to 2021. 2019 was the busiest year, with 2. The most frequent topics are Pulmonary Disease, Chronic Obstructive, Lung and Rural Health. Dr. Atkins' most frequent co-authors are Daniel S. Aridgides, MD, PhD, Alix Ashare, MD and James L. Carroll, MD.

CMS Open Payments shows 1 general payment to Dr. Atkins from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Breathe Technologies, Inc. paid the most, $13.